Cargando…
Recent advances in the development of p21-activated kinase inhibitors
The p21-activated kinases (PAKs) are downstream effectors of the small G-proteins of the Rac and cdc42 family and have been implicated as essential for cell proliferation and survival. Recent studies have also demonstrated the promise of PAKs as therapeutic targets in various types of cancers. The P...
Autores principales: | Coleman, Natalia, Kissil, Joseph |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3490963/ https://www.ncbi.nlm.nih.gov/pubmed/23162744 http://dx.doi.org/10.4161/cl.21667 |
Ejemplares similares
-
Recent advances on development of p21-activated kinase 4 inhibitors as anti-tumor agents
por: Li, Yang, et al.
Publicado: (2022) -
Recent Advances in the Development and Application of Radiolabeled Kinase Inhibitors for PET Imaging
por: Bernard-Gauthier, Vadim, et al.
Publicado: (2015) -
p-21 Activated Kinase as a Molecular Target for Chemoprevention in Diabetes †
por: Dammann, Kyle, et al.
Publicado: (2018) -
Recent Advances in Pain Management: Relevant Protein Kinases and Their Inhibitors
por: Giraud, Francis, et al.
Publicado: (2021) -
P-21 Activated Kinases in Liver Disorders
por: Qiu, Xun, et al.
Publicado: (2023)